Berberine — research review 3

...and that’s where something like berberine comes into play. It’s a plant alkaloid that activates AMPK, the cellular fuel-deficiency sensor.

Right, so it essentially mimics what happens during calorie restriction or even exercise. We know that endurance exercise perturbs cellular energy balance and activates AMPK, as discussed in Cell Metabolism in 2018. Fasting and dietary restriction also activate AMPK, as Nat Rev Mol Cell Biol explained in 2021.

Exactly. Berberine is thought to act as a calorie-restriction mimetic, safely activating AMPK to potentially lower cardiometabolic risk and extend healthspan. A 2013 paper in Age (Dordr) states that nutraceuticals like berberine can be employed as clinical AMPK activators.

And beyond activating AMPK directly, it has other interesting downstream effects. Open Heart in 2022 noted that berberine can increase the expression of nicotinamide phosphoribosyltransferase, or NAMPT, which is rate-limiting for NAD+ synthesis.

Which then ties into SIRT1 activation, right? The same Open Heart paper from 2022 also mentioned that AMPK amplifies SIRT1 activity by promoting NAMPT, which provides SIRT1’s necessary substrate, NAD+. And it even seems to inhibit inflammation. Nutrients in 2020 indicated that berberine, an AMPK activator, may suppress inflammasome activity, specifically the NLRP3 inflammasome.

So, we have several mechanisms linking berberine to benefits. But what’s still genuinely unknown here? We have these pathways, but how much do we truly understand about its long-term impact on human longevity?

That’s the big question. While the molecular mechanisms are becoming clearer, the direct evidence showing berberine extending human healthspan or lifespan is still developing. We have these powerful connections to established longevity pathways, but translating that into definitive human outcomes over decades is the unproven part.